Establishing a high-risk neuroblastoma cohort using the Pediatric Health Information System Database

Ami V Desai1,2,3, Marko Kavcic1, Yuan-Shung Huang4

  • 1Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Insights

Identifying high-risk neuroblastoma patients in administrative data is challenging due to missing International Classification of Diseases, 9th Revision (ICD-9) codes. A validated algorithm using ICD-9 codes, exclusion criteria, and chemotherapy data successfully identified a high-risk neuroblastoma cohort.

Area of Science:

  • Pediatric Oncology
  • Health Informatics
  • Clinical Epidemiology

Background:

  • The absence of specific International Classification of Diseases, 9th Revision (ICD-9) codes for neuroblastoma hinders patient identification in administrative databases.
  • Accurate patient identification is crucial for epidemiological studies and comparative effectiveness research in pediatric cancers.

Purpose of the Study:

  • To develop and validate a reliable algorithm for identifying a high-risk neuroblastoma cohort within the Pediatric Health Information System (PHIS) database.
  • To create a valuable data resource for future research on high-risk neuroblastoma.

Main Methods:

  • A three-step algorithm was designed, incorporating ICD-9 codes, specific exclusion criteria, and manual review of chemotherapy billing data.
  • The algorithm was applied to the PHIS database to assemble a cohort of high-risk neuroblastoma patients (n = 952).
  • Validation was performed at a single institution, assessing sensitivity and positive predictive value (PPV).

Main Results:

  • The developed algorithm demonstrated high performance, achieving a sensitivity of 89.1% and a positive predictive value (PPV) of 96.1%.
  • A cohort of 952 high-risk neuroblastoma patients was successfully identified and assembled.
  • The methodology provides a robust approach for identifying similar patient cohorts in administrative datasets.

Conclusions:

  • The algorithm effectively overcomes the limitation of missing ICD-9 codes for neuroblastoma identification.
  • The identified high-risk neuroblastoma cohort serves as a valuable resource for future clinical epidemiology and comparative effectiveness studies.
  • This approach enhances the utility of administrative databases for research in rare pediatric cancers.

Related Concept Videos